Table 1:

Clinical and Genetic Information for Patients Included in the Analysis (n=201)

		N (%)
Sex	Male	143 (71.1%)
	Female	58 (28.9%)
Self-reported Race	Caucasian	196 (97.5%)
	Asian	2 (1.0%)
	Black	1 (0.5%)
	American Indian/Pacific Islander	1 (0.5%)
	Unknown/Not Reported	1 (0.5%)
Indication	Actinic Keratosis	159 (79.1%)
	Verruca	22 (9.14%)
	Warts	10 (5.0%)
	Other	10 (5.0%)
DPYD Genotype	DPYD*1/*1 (Wild-type)	187 (93.0%)
	DPYD*1/*2A (AS=1.0)	3 (1.5%)
	DPYD*1/*13 (AS=1.0)	0
	DPYD*1/p.D949V (AS=1.5)	1 (0.5%)
	DPYD*1/HapB3 (AS=1.5)	10 (5.0%)
	DPYD*1/p.Y186C (AS=1.5)	0
	Total variant carriers	14 (7.0%)
Observed Toxicity	Grade 1+ Dermatological Toxicity	22 (10.9%)
	Grade 3+	0 (0%)